Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Hepatocellular × Cyclosporine × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia 50 Leukemia, Myeloid, Acute 46 Myelodysplastic Syndromes 45 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Leukemia, Lymphocytic, Chronic, B-Cell 38 Lymphoma, Non-Hodgkin 34 Hodgkin Disease 31 Multiple Myeloma 29 Lymphoma, Mantle-Cell 29 Lymphoma, Large B-Cell, Diffuse 27 Lymphoma 27 Lymphoma, Follicular 26 Leukemia, Myeloid, Chronic-Phase 26 Lymphoma, B-Cell, Marginal Zone 24 Burkitt Lymphoma 22 Congenital Abnormalities 21 Myeloproliferative Disorders 20 Lymphoma, Large-Cell, Immunoblastic 20 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Anemia, Refractory, with Excess of Blasts 20 Leukemia, Myeloid, Accelerated Phase 19 Leukemia, Myelomonocytic, Chronic 18 Blast Crisis 18 Graft vs Host Disease 17 Recurrence 15 Dendritic Cell Sarcoma, Interdigitating 15 Anemia, Refractory 15 Waldenstrom Macroglobulinemia 13 Neoplasms, Plasma Cell 13 Myelodysplastic-Myeloproliferative Diseases 11

Interventions

Sorafenib 62 Bevacizumab 59 lenvatinib 52 durvalumab 35 atezolizumab 27 sintilimab 26 Nivolumab 26 pembrolizumab 24 Oxaliplatin 24 tremelimumab 22 tislelizumab 22 Fluorouracil 21 apatinib 20 Radiosurgery 19 camrelizumab 18 regorafenib 15 cabozantinib 15 Doxorubicin 15 Leucovorin 14 Capecitabine 13 Radiotherapy 12 Folfox protocol 12 donafenib 11 Gemcitabine 10 Cisplatin 10 Immune Checkpoint Inhibitors 9 Erlotinib Hydrochloride 9 toripalimab 8 Neoadjuvant Therapy 8 Immunotherapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01374750 2016-06-01

Sirolimus

Seoul National University Hospital

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡